• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

充血性心力衰竭或心肌梗死患者心脏结局的无创风险评估与预测

Noninvasive risk assessment and prediction of cardiac outcomes in patients with congestive heart failure or myocardial infarction.

作者信息

Kim Ju Youn, Park Young Jun, Park Seung-Jung, Kim Juwon, Park Kyoung-Min, On Young Keun, Kim June Soo, Nam Gi-Byoung, Lee Young Soo, Kim Dae Hyeok, Ahn Minsoo, Shin Dong-Gu, Kim Nam-Ho, Namgung June, Park Yae Min, Park Hyoung-Seob

机构信息

Division of Cardiology, Department of Internal Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Wonju Severance Christian Hospital, Department of Internal Medicine, Yonsei University, Wonju College of Medicine, Wonju, Republic of Korea.

出版信息

Heart Rhythm. 2025 Apr;22(4):1030-1039. doi: 10.1016/j.hrthm.2024.10.012. Epub 2024 Oct 10.

DOI:10.1016/j.hrthm.2024.10.012
PMID:39395571
Abstract

BACKGROUND

Heart rate turbulence (HRT) and T-wave alternans (TWA), recognized as promising noninvasive markers for ventricular tachyarrhythmias and cardiac death, have been studied predominantly in Western populations, specifically in patients with myocardial infarction (MI) or heart failure (HF) with reduced ejection fraction (EF).

OBJECTIVE

The purpose of this study was to investigate the clinical implications of HRT and TWA in predicting adverse cardiac events, including cardiac death, ventricular tachyarrhythmia, and heart failure-related hospitalization (HFH).

METHODS

The K-REDEFINE study, a prospective, observational, multicenter analysis of 26 tertiary hospitals in South Korea, investigated the prognostic implications of Holter-based variables including HRT and TWA in 1116 patients with acute MI or HF (age 60.8 ± 2.9 years; 76.3% male). All participants underwent 24-hour Holter recording within 6.8 ± 16.5 days after hospitalization. The primary composite outcome included cardiac death, ventricular tachyarrhythmias, and HFH.

RESULTS

During 4.3 ± 1.2 years of follow-up, impaired HRT demonstrated the most powerful predictive value for the composite (adjusted hazard ratio [aHR] 3.41, 95% confidence interval [CI] 2.27-5.13) or individual events: cardiac death (aHR 4.08, 95% CI 2.17-7.70), ventricular tachyarrhythmia (aHR 3.72, 95% CI 1.29-10.77), and HFH (aHR 4.32, 95% CI 2.25-8.28). The predictive power of abnormal HRT remained consistently significant across subgroups of MI and HF, or across varying degrees of EF. When combined with reduced EF (<50%), the predictive power was further enhanced. However, abnormal TWA was significantly associated only with the composite outcome (aHR 1.51, 95% CI 1.06-2.16).

CONCLUSION

The K-REDEFINE study identified abnormal HRT, mostly assessed within 1 month after hospitalization, as a significant predictor not only for cardiac death and ventricular tachyarrhythmia but also for HFH.

摘要

背景

心率震荡(HRT)和T波电交替(TWA)被认为是预测室性快速心律失常和心源性死亡的有前景的无创标志物,主要在西方人群中进行了研究,特别是在心肌梗死(MI)或射血分数降低(EF)的心力衰竭(HF)患者中。

目的

本研究旨在探讨HRT和TWA在预测不良心脏事件(包括心源性死亡、室性快速心律失常和心力衰竭相关住院(HFH))中的临床意义。

方法

K-REDEFINE研究是一项对韩国26家三级医院进行的前瞻性、观察性、多中心分析,研究了基于动态心电图的变量(包括HRT和TWA)对1116例急性MI或HF患者(年龄60.8±2.9岁;76.3%为男性)的预后影响。所有参与者在住院后6.8±16.5天内进行了24小时动态心电图记录。主要复合结局包括心源性死亡、室性快速心律失常和HFH。

结果

在4.3±1.2年的随访期间,HRT受损对复合结局(调整后危险比[aHR]3.41,95%置信区间[CI]2.27-5.13)或个体事件显示出最强的预测价值:心源性死亡(aHR 4.08,95%CI 2.17-7.70)、室性快速心律失常(aHR 3.72,95%CI 1.29-10.77)和HFH(aHR 4.32,95%CI 2.25-8.28)。异常HRT的预测能力在MI和HF亚组中或不同EF程度中始终保持显著。当与EF降低(<50%)相结合时,预测能力进一步增强。然而,异常TWA仅与复合结局显著相关(aHR 1.51,95%CI 1.06-2.16)。

结论

K-REDEFINE研究确定,主要在住院后1个月内评估的异常HRT不仅是心源性死亡和室性快速心律失常的重要预测指标,也是HFH的重要预测指标。

相似文献

1
Noninvasive risk assessment and prediction of cardiac outcomes in patients with congestive heart failure or myocardial infarction.充血性心力衰竭或心肌梗死患者心脏结局的无创风险评估与预测
Heart Rhythm. 2025 Apr;22(4):1030-1039. doi: 10.1016/j.hrthm.2024.10.012. Epub 2024 Oct 10.
2
Beta-Blockers for Secondary Prevention following Myocardial Infarction in Patients Without Reduced Ejection Fraction or Heart Failure: An Updated Meta-Analysis.射血分数未降低或无心力衰竭的心肌梗死患者二级预防用β受体阻滞剂:一项更新的荟萃分析。
Eur J Prev Cardiol. 2024 Sep 20. doi: 10.1093/eurjpc/zwae298.
3
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
4
Long-term benefit of vasodilating beta-blockers in acute myocardial infarction patients with mildly reduced left ventricular ejection fraction.血管舒张性β受体阻滞剂对左心室射血分数轻度降低的急性心肌梗死患者的长期益处。
PLoS One. 2025 Jun 23;20(6):e0326516. doi: 10.1371/journal.pone.0326516. eCollection 2025.
5
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
6
Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohort.急性冠状动脉综合征后左心室射血分数正常或轻度降低时停用β受体阻滞剂的安全性:来自真实世界队列的目标试验模拟
Eur J Prev Cardiol. 2024 Oct 26. doi: 10.1093/eurjpc/zwae346.
7
Inpatient versus outpatient diagnosis of heart failure across the spectrum of ejection fraction: a population cohort study.射血分数全谱范围内心力衰竭的住院与门诊诊断:一项人群队列研究。
Heart. 2025 May 12;111(11):523-531. doi: 10.1136/heartjnl-2024-324160.
8
Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials.比较 2 型糖尿病和心力衰竭患者中不同 SGLT2 抑制剂的心血管获益:一项随机对照试验的系统评价和网络荟萃分析。
Front Endocrinol (Lausanne). 2023 Dec 20;14:1216160. doi: 10.3389/fendo.2023.1216160. eCollection 2023.
9
Prognostic Significance of Nutritional Scores in Patients With Heart Failure: Insights From the PARAGON-HF Trial.心力衰竭患者营养评分的预后意义:PARAGON-HF试验的见解
J Am Heart Assoc. 2025 May 6;14(9):e038872. doi: 10.1161/JAHA.124.038872. Epub 2025 Apr 23.
10
Patient education in the management of coronary heart disease.冠心病管理中的患者教育
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3.